HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Stefan Bourgeois Selected Research

Stefan Bourgeois Research Topics

Disease

18Infections
01/2023 - 05/2013
10Fibrosis (Cirrhosis)
01/2023 - 02/2016
6Chronic Hepatitis C
12/2021 - 06/2012
3Chronic Hepatitis B
01/2023 - 01/2019
2Hepatitis C
01/2017 - 01/2017
1Hepatitis B
01/2023
1Persistent Infection
01/2020
1Peptic Ulcer (Peptic Ulcers)
01/2019
1Gastroesophageal Reflux (GERD)
01/2019
1Virus Diseases (Viral Diseases)
01/2017
1Liver Diseases (Liver Disease)
01/2017
1Dumping Syndrome (Syndrome, Dumping)
04/2009

Drug/Important Bio-Agent (IBA)

8Ribavirin (Virazole)FDA LinkGeneric
02/2017 - 05/2015
7SimeprevirIBA
01/2019 - 05/2015
5Antiviral Agents (Antivirals)IBA
01/2020 - 05/2013
5InterferonsIBA
01/2019 - 01/2017
4SofosbuvirIBA
01/2023 - 01/2017
3Hepatitis B e AntigensIBA
01/2023 - 01/2019
3velpatasvirIBA
01/2023 - 01/2018
3Protease Inhibitors (Protease Inhibitor)IBA
12/2017 - 06/2012
2JNJ-56136379IBA
01/2023 - 01/2020
2Hepatitis B Surface Antigens (HBsAg)FDA Link
01/2023 - 05/2013
2glecaprevir and pibrentasvirIBA
12/2021 - 12/2021
2ombitasvirIBA
01/2019 - 02/2016
2paritaprevirIBA
01/2019 - 02/2016
2Ritonavir (Norvir)FDA Link
02/2017 - 02/2016
1Tenofovir (Viread)FDA Link
01/2023
1AntigensIBA
01/2023
1entecavirFDA Link
01/2023
1TabletsIBA
01/2023
1Alanine Transaminase (SGPT)IBA
01/2023
1DNA (Deoxyribonucleic Acid)IBA
01/2021
1Antipsychotic Agents (Antipsychotics)IBA
01/2019
1odalasvirIBA
01/2019
1Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA
01/2019
1Anticonvulsants (Antiepileptic Drugs)IBA
01/2019
1ledipasvirIBA
12/2017
1sofosbuvir drug combination ledipasvirIBA
12/2017
1GSK2336805IBA
02/2017
127- cyclohexyl- 12,13,16,17- tetrahydro- 22- methoxy- 11,17- dimethyl- 10,10- dioxide- 2,19- methano- 3,7:4,1- dimetheno- 1H,11H- 14,10,2,9,11,17- benzoxathiatetraazacyclo docosine-8,18(9H,15H)-dioneIBA
02/2017
1daclatasvirIBA
01/2017
1dasabuvirIBA
02/2016
1RNA (Ribonucleic Acid)IBA
05/2013
1Somatostatin (Somatotropin Release-Inhibiting Factor)IBA
04/2009
1Octreotide (Sandostatin)FDA LinkGeneric
04/2009

Therapy/Procedure

3Therapeutics
01/2017 - 05/2013
2Aftercare (After-Treatment)
01/2018 - 01/2017
2Opiate Substitution Treatment
01/2017 - 01/2017